Sunridge signs distribution agreement with Ameco Medical Equipment

NewsGuard 100/100 Score

Sunridge International (OTC Bulletin Board: SNDZ) announced today that it has signed an agreement with Ameco Medical Equipment L.L.C. for distribution rights in several Middle Eastern countries.  The five-year contract valued at over 6.5 million dollars will start immediately.

As part of their marketing strategies, Ameco Medical will initiate a short study to involve local key opinion leaders with first hand experience with Pneumatic Trabeculoplasty (PNT), and to facilitate government reimbursement for the procedure within the region.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (www.oi-pnt.com).

Source:

Sunridge International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advanced neuroimaging reveals surprising link between glaucoma and Alzheimer's disease